The tweet was deleted by the author.
But we saved everything 🙂.
Heineken states that GLP-1 drugs such as Ozempic are reducing the desire to drink through “fullness and fewer serves.” Drinking frequency among clients has already fallen 29%. Experts believe Ozempic adoption may reach seven million adults in Britain by 2027. So can brewers adjust their strategies to effectively react to the structural shift in volume?
Heineken owns more than 2,000 pubs in Britain. The company recommended operators to promote half-pints and rely on low- and no-alcohol options. This is the way to deal with the growing declines in visits and spending.
“We see some changes in consumption behavior among (GLP-1) users and will continue to monitor how these behaviors evolve in 2027,” Heineken said. However, urgent measures are expected to be taken immediately.
View post on X Loading...
Users are not abandoning alcohol entirely, but they tend to prefer smaller serves and more premium products. Earlier, major alcohol companies described GLP-1 impact as comparatively insignificant. However, Heineken’s decision to brief its pub estate confirms that the threat is real, and operational changes have become the objective necessity this year.
Market research firm Circana tracked US households between 2024 and 2026. After two years, those with a GLP-1 user spent about 7% less per month on alcohol than average households. The impact on beer was even higher: minus 13.5%, including both at-home and out-of-home purchases. In the UK, research by consultancy KAM and the charity Drinkaware found that people taking GLP-1 reduced their drinking frequency by almost 30%. Weekly alcohol consumption fell 16%, from 4.3 to 3.6 units.
View post on X Loading...
Spending on alcohol for home consumption dropped 22%. Pubs, bars and restaurants experienced the reduction in revenues by 30%. Thirty-four percent of users reported the reduced interest in alcohol, while 18% said drinking caused physical discomfort such as nausea. JPMorgan estimates that 10 million people in the United States used medications such as Ozempic and Wegovy last year.
In Britain, the number of adults using GLP-1 could reach three million to seven million by 2027. Heineken’s UK data show beer generated £14 billion in sales across pubs, bars, and restaurants and £300 million of that amount was generated by no- and low-alcohol products.
Beer is subject to the highest decline in demand compared with other alcohol categories. Multi-serve occasions are the main behavior the drugs disrupt. Ten of the 11 GLP-1 users interviewed by Reuters said they had cut back, and in most cases, the Scottish Licensed Trade Association survey confirmed that a 16% decline in visits was caused by the weight-loss drugs.
View post on X Loading...
Joseph Schacht, a professor of psychiatry at the University of Colorado Anschutz, has described the potential therapeutic effect as a possible “Prozac moment” for addiction treatment. The mechanism that helps patients with alcohol use disorder also creates commercial pressure for producers, as even groups of moderate drinkers also reduce their intake.
Heineken’s recommendations are practical, as smaller glass sizes may protect some revenue while recognizing reduced appetite. Low- and no-alcohol ranges give customers a reason to stay in the venue. Small plates rather than large meals can allow pubs to find a balance between clients’ loyalty and sufficient spending. However, other innovations may also be needed.
View post on X Loading...
The brewer states its portfolio may facilitate the shift toward premium and lower-alcohol products. Other operators have not disclosed their plans yet. The challenge is to convert volume loss into some gains. In particular, it is crucial to maintain the overall traffic at the satisfactory level. Those restaurants that cannot adjust their policies may experience both lower average spending and fewer visits.
The GLP-1 effect contributes to other issues: health-driven moderation, cost of living, and generational shifts. All of them explain a lower than before popularity of heavy drinking. Europe remains Heineken’s largest revenue region; any volume pressure in the UK and similar markets can threaten the overall growth. Investors will monitor whether companies can defend margins through pricing and assortment decisions.
View post on X Loading...
Early movers that expand low- and no-alcohol offerings as well as redesign on-trade solutions perceive the trend as sustainable. They may prove to be more efficient than those ignoring the latest developments. Experts will continue analyzing the situation in the industry, but consumer spending data indicate that the traditional multi-pint economy is rapidly transforming into new consumer-oriented models.